LEADER 04011nam  22006135  450 
001 9910300169703321
005 20200702172453.0
010   $a3-319-18994-8
024 7 $a10.1007/978-3-319-18994-9
035   $a(CKB)3710000000436848
035   $a(EBL)3567513
035   $a(SSID)ssj0001525170
035   $a(PQKBManifestationID)11900764
035   $a(PQKBTitleCode)TC0001525170
035   $a(PQKBWorkID)11485298
035   $a(PQKB)11052755
035   $a(DE-He213)978-3-319-18994-9
035   $a(MiAaPQ)EBC3567513
035   $a(PPN)186396260
035   $a(EXLCZ)993710000000436848
100   $a20150630d2015      u|             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAtlas of PET-CT Imaging in Oncology$b[electronic resource] $eA Case-Based Guide to Image Interpretation /$fby Tamer Özülker, Filiz Özülker
205   $a1st ed. 2015.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015.
215   $a1 online resource (479 p.)
300   $aDescription based upon print version of record.
311   $a3-319-18993-X 
320   $aIncludes bibliographical references and index at the end of each chapters.
327   $aPart I Fundamentals: Normal Physiology -- Normal Variants and Benign Findings -- Incidental Findings on PET Studies -- Findings that should be reported on CT (or Urgent/Emergent CT Findings) -- Part II: Oncologic Applications -- Head and Neck Cancer -- Thyroid Cancer -- Brain Neoplasms -- Thoracic Neoplasms -- Breast Cancer -- Gastric, Esophageal and Small Bowel Cancers -- Pancreas Cancer -- Gall Bladder Carcinoma -- Colorectal Cancer -- Musculoskeletal Tumors -- Gynecologic Tumors -- Urologic Tumors -- Surrenal Tumors -- Multiple myeloma -- Lymphoma -- Melanoma -- Carcinoma of Unknown Primary -- Others.
330   $aThis atlas is a case-based guide to the interpretation of FDG PET-CT images in clinical scenarios faced by physicians during the routine practice of oncology. The book aims to help the practitioner to overcome diagnostic dilemmas through familiarization with the physiologic distribution of FDG, normal variants, and benign findings. It includes a rich variety of atypical incidental findings which are rarely seen but may give rise to inconclusive reports. The main focus, however, is the imaging of major oncological diseases, including the rare ones. Different pathologies are addressed in individual chapters comprising teaching files of cases, each of which corresponds to a common indication for PET-CT imaging. These indications include metabolic characterization of lesions, detection of an unknown primary, staging, restaging, and evaluation of response to therapy. Each case is accompanied by a succinct explanation of the patient?s history, interpretation of the PET-CT study, and a teaching point which is often supported by relevant literature. This book will be of great value to residents and practitioners in nuclear medicine, radiology, oncology, radiation oncology, and nuclear medicine technology.
606   $aNuclear medicine
606   $aOncology  
606   $aOrthopedics
606   $aNuclear Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H29048
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
606   $aOrthopedics$3https://scigraph.springernature.com/ontologies/product-market-codes/H45000
615  0$aNuclear medicine.
615  0$aOncology  .
615  0$aOrthopedics.
615 14$aNuclear Medicine.
615 24$aOncology.
615 24$aOrthopedics.
676   $a610
700   $aÖzülker$b Tamer$4aut$4http://id.loc.gov/vocabulary/relators/aut$0789157
702   $aÖzülker$b Filiz$4aut$4http://id.loc.gov/vocabulary/relators/aut
906   $aBOOK
912   $a9910300169703321
996   $aAtlas of PET-CT Imaging in Oncology$92535759
997   $aUNINA